After the really interesting recent study by @Chris Ponting showing some markers of insulin resistance in ME patients, the question arises, why would the HbA1c not be indicating insulin resistance in these patients?
I have seen Continuous Glucose Monitor (CGM) charts of people with ME, and there are many who seem to have pre-diabetic fasting glucose on the chart but the HbA1c is normal.
Research by Ron Davis has shown that ME patients have diminished red blood cell deformability.
https://content.iospress.com/articles/clinical-hemorheology-and-microcirculation/ch180469
Red blood cells with diminished deformability have a shorter life span.
HbA1c measures the average glucose level over the past 2-3 months by calculating the percentage of glycated hemoglobin in red blood cells. But if ME red blood cells are less deformable and have a shorter lifespan, this might lower the HbA1c test result.
I have been trying to think of a way to test this theory. Fructosamine is another marker that reflects blood sugar levels over the last 2-3 weeks, based on glycated serum proteins, not red blood cells. Could this give us a more accurate picture of insulin resistance in ME patients?
I am thinking of organising a patient-led project to collect the Fructosamine tests of people with ME. The HbA1c would need to be tested at the same time, to compare.
I have been speaking to the Renegade Research/ Remission Biome group about this as they have already been doing patient-led research.
It might only be worth ME patients who suspect insulin issues doing this test (for example people who do better on low carbohydrate diets or who have higher fasting glucose levels).
I'm interested in people's opinions on this idea.
I have seen Continuous Glucose Monitor (CGM) charts of people with ME, and there are many who seem to have pre-diabetic fasting glucose on the chart but the HbA1c is normal.
Research by Ron Davis has shown that ME patients have diminished red blood cell deformability.
https://content.iospress.com/articles/clinical-hemorheology-and-microcirculation/ch180469
Red blood cells with diminished deformability have a shorter life span.
HbA1c measures the average glucose level over the past 2-3 months by calculating the percentage of glycated hemoglobin in red blood cells. But if ME red blood cells are less deformable and have a shorter lifespan, this might lower the HbA1c test result.
I have been trying to think of a way to test this theory. Fructosamine is another marker that reflects blood sugar levels over the last 2-3 weeks, based on glycated serum proteins, not red blood cells. Could this give us a more accurate picture of insulin resistance in ME patients?
I am thinking of organising a patient-led project to collect the Fructosamine tests of people with ME. The HbA1c would need to be tested at the same time, to compare.
I have been speaking to the Renegade Research/ Remission Biome group about this as they have already been doing patient-led research.
It might only be worth ME patients who suspect insulin issues doing this test (for example people who do better on low carbohydrate diets or who have higher fasting glucose levels).
I'm interested in people's opinions on this idea.